The Pharma Data

DECEMBER 17, 2020

Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Recro – CDMO company Recro announced David Enloe as its new president and CEO.

Small Molecule 52

Small Molecule Engineering Pharmaceuticals Clinical Development 52

PerkinElmer

FEBRUARY 18, 2021

“To lead in product development and partner with customers in solving everyday challenges, we gather information regularly about current practices and future trends,” said Volker Eckelt, PhD, Senior Strategy Leader, PerkinElmer Life Sciences. By a 3:1 margin, PerkinElmer found top Pharma screens for a specific target.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

Drug Discovery World

AUGUST 7, 2024

The rest of the pharma R&D system — how drugs are developed, tested, approved, and manufactured — will need to accommodate this vast increase in speed and scale. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173

Dark Matter Blog

JUNE 21, 2023

Since our company’s founding in 2015, we have taken the long view and been singularly focused on building an extremely flexible and broadly applicable platform that can develop a host of RNA‑targeted small molecules (rSMs) to deliver precision medicines for dozens of targets that have been out of reach for conventional approaches.

Small Molecule 52

Small Molecule RNA Pharma Companies Science 52

Drug Discovery World

JANUARY 3, 2023

In the 13 years since it was first described, DNA-encoded library (DEL) technology has become a firmly established approach to small molecule hit generation in drug discovery. Most major pharma companies operate DEL platforms, and several service providers offer DEL capabilities to companies that outsource their DEL activities.

DNA 130

DNA Targeted Protein Degradation Small Molecule Pharma Companies 130

Drug Discovery World

OCTOBER 7, 2022

It brings together our commercialisation and therapeutic innovation capabilities – as a ‘one stop shop’ for industry and investors to access Cancer Research UK’s (CRUK) science. It is about going faster in progressing our innovation to market, taking things further along the value chain as we de-risk the early science. Hamish Ryder.

Pharma Companies 130

Pharma Companies Science Research Drug Development 130

Drug Discovery World

JANUARY 26, 2023

As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities. According to research from Deloitte 1 , the average ROI in R&D for global pharma companies fell to just 1.2% in 2022, a steep decline compared to the record 6.8% the industry experienced in 2021.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

AUGUST 5, 2022

An increasing number of academic groups, start-ups, biotechs and small pharma companies are turning to external consultants for professional programme management support and guidance to help them progress their ideas into medicines for patients. Why sponsors use external consultants.

Drug Development 130

Drug Development Drugs Pharma Companies International 130

Drug Discovery World

NOVEMBER 15, 2022

The brainchild of multidisciplinary experts in computer science, physics, engineering, and biology, the field of synthetic biology has not only rapidly progressed in the last few decades but it’s also becoming more accessible and cost-effective. The results of the study appeared in Science Translational Medicine earlier this year 2. .

DNA 246

DNA Engineering Drugs Vaccine 246

Drug Target Review

MAY 23, 2023

Credit: European Science Communication Institute The human microbiota is fundamental to correct functioning of tissue homeostasis, actively interacting with the host on different levels including mucosal surfaces of which the gastrointestinal tract is the most colonised.

Drugs 75

Drugs Small Molecule Production Pharma Companies 75

Nvidia Developer: Drug Discovery

FEBRUARY 14, 2024

billion in silico-generated small molecule compounds for screening, including 25 known to bind FADS1 (known as ligands ). Further development of this technology stack will target creating high-performance AI-based drug discovery platforms for a wide range of biotech and pharma companies. Receptor.AI

Drugs 134

Drugs Small Molecule Pharma Companies Therapies 134

Drug Target Review

APRIL 19, 2024

The discovery of the folding intermediate states to target has been enabled by our proprietary computational platform, and the development of small molecule folding interfering degraders is now accelerated by a proprietary AI platform. As a woman in STEM, what unique perspectives or strengths do you believe you bring to your work?

Molecular Biology 111

Molecular Biology Pharmaceuticals Small Molecule Research 111

Vial

FEBRUARY 19, 2024

Can you elaborate on how the platform allows your company to tailor therapy? We can link small molecule drugs to a payload that would enter in the cell and kill it. We have the capability of different types of targets, whether small molecules or antibodies. Ahmed Hamby: We also have a very cool modification.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

Elrig

APRIL 29, 2024

During this time, I had the opportunity to step in as an interim Discovery Sciences project lead, sparking my interest in project leadership. There, I supported AI-enabled DD efforts in their small molecule portfolio. big pharma or startups/spin off? Where do you enjoy more to work? What pro/cons?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59